Lexeo Therapeutics, Inc., a clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States. Its product pipeline comprises LX2006, an AAVrh10-based gene therapy candidate, whic...
Leadership
R. Nolan Townsend M.B.A.
CEO & Director
Louis Tamayo
CFO & Principal Accounting Officer
Ronald G. Crystal M.D.Founder
Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory Board
